Merck & Co Inc/ US58933Y1055 /

6/18/2021 9:59:59 PM	Chg. -0.59	Volume	Bid-	Ask-	Market Capitalization	Dividend Y.	P/E Ratio
76.65USD	-0.76%	347,463 Turnover: 26.66 mill.	-Bid Size: -	-Ask Size: -	193.82 bill.USD	3.24%	27.46

TeleTrader 6/9 Merck, US govt sign deal on oral COVID treatment

GlobeNewswire 5/6 NGM Bio Provides Business Highlights and Reports First Quarter 2021 Financial Results

TeleTrader 4/29 Merck misses estimates with $12.1B revenue in Q1

TeleTrader 4/15 Merck to scrap COVID drug for hospitalized patients

GlobeNewswire 4/15 Arch Biopartners Enters into Worldwide License Agreement with Telara Pharma to Re-Purpose Cilastatin...

GlobeNewswire 4/8 Immutep Achieves Fast Track Designation From US FDA For Efti, A Soluble Lag-3 Protein, In First Line...

GlobeNewswire 4/7 PRA’s remote patient monitoring platform selected by Merck KGaA, Darmstadt, Germany to work in combi...

GlobeNewswire 3/18 Trevena, Inc. Appoints Marvin H. Johnson, Jr. to Board of Directors

GlobeNewswire 3/16 Immutep Enters Second Collaboration With MSD For A New Randomised Phase IIB Trial In Head And Neck C...

TeleTrader 3/15 Gilead, Merck jointly developing new HIV drug

TeleTrader 3/10 J&J to deliver additional 100M doses in H2 - WH

TeleTrader 3/10 Report: US wants to buy 100M more J&J vaccine doses

TeleTrader 3/6 COVID-19 drug efficient in reducing infection after 5 days - trial

TeleTrader 3/2 WH: Biden admin sped up J&J, Merck deal

TeleTrader 3/2 Merck to help J&J manufacture COVID vaccine - report

TeleTrader 2/25 Merck to buy Pandion in $1.8 billion cash deal

TeleTrader 2/4 Merck to appoint Robert Davis as new CEO

TeleTrader 2/4 Merck sales rise 5% to $12.5B in Q4

GlobeNewswire 1/19 Cocrystal Pharma Announces Further Development of Influenza A/B Antiviral Compounds by Merck under E...

TeleTrader 12/23/2020 Merck, US gov't sign COVID therapeutic supply deal

TeleTrader 12/2/2020 Merck divests direct holding in Moderna

TeleTrader 11/23/2020 Merck to buy COVID therapy candidate maker OncoImmune

GlobeNewswire 11/10/2020 An Agenus-discovered first-in-class ILT4 antibody, MK-4830, enters Phase 2

TeleTrader 10/27/2020 Merck revenue rises 1% YoY to $12.6B in Q3

GlobeNewswire 9/17/2020 Vaccinex Announces Clinical Collaboration with Merck to Evaluate Pepinemab in Combination with KEYTR...